Quantitative Investment Management, LLC Bristol Myers Squibb CO Transaction History

Quantitative Investment Management, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $12.4 Million - $16.4 Million	309,026 Added 2011.36%	324,390 $13.5 Million
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $395,835 - $448,800	-8,250 Reduced 34.94%	15,364 $833,000
Q4 2023 Feb 13, 2024	BUY	$48.48 - $57.85 $1.14 Million - $1.37 Million	23,614 New	23,614 $1.21 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $838,359 - $930,867	13,159 New	13,159 $841,000
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $8.12 Million - $9.51 Million	-137,230 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $7.92 Million - $8.63 Million	127,939 Added 1377.02%	137,230 $9.17 Million
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $551,327 - $620,081	9,291 New	9,291 $586,000
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $1.54 Million - $1.74 Million	-26,612 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $10.8 Million - $12 Million	-187,953 Reduced 87.6%	26,612 $1.6 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $2.62 Million - $3.07 Million	47,830 Added 28.69%	214,565 $12.6 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $7.74 Million - $11.2 Million	166,735 New	166,735 $9.29 Million
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $8.32 Million - $9.92 Million	-184,300 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$48.76 - $63.23 $8.99 Million - $11.7 Million	184,300 New	184,300 $9.58 Million
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $731,268 - $797,269	-12,200 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $673,806 - $777,628	12,200	12,200 $777,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Investment Management, LLC with notifications on news.